Table 3.
Author, year | OAR | Time point | Main findings |
---|---|---|---|
Cheng, 2013 [22] | PG | BL Mean 53d post-RT |
Post-RT, PGs showed a sign. higher A (+87%), peak enhancement (+93%, in all patients higher than BL values), wash-in slope (+73%) and a sign. lower Kel (−57%). No sign. change in k21 and TTP. Only peak enhancement with sign. positive correlation to dose. Kel and slope with sign. negative and TTP with sign. positive correlation to PSV. |
Houweling, 2011 [23] | PG, SMG | BL 6w post-RT |
Sign increase post-RT in ve (+33%/+23%) and sign. decrease in kep (−16%/−24%) in PGs and SMGs, respectively. No sign. difference from BL to post-RT in ktrans and vp. |
Lee, 2011 [24] | PG | BL 3 m post-RT |
Sign. increase in ktrans (+71%), ve (+93%), vp (+477%) post-RT. |
BL: baseline, k21: contrast exchange rate constant, kel: elimination transfer rate, kep: flux rate constant, ktrans: volume transfer coefficient, m: month, OAR: organ at risk, PG: parotid gland, PSV: parotid sparing volume, defined as percentage of PG receiving < 25 Gy, RT: radiotherapy, sign.: significant, SMG: submandibular gland, TTP: time-to-peak, ve: extravascular volume fraction, vp: vascular plasma space, w: week.